Loomis Sayles & CO L P Pacira Bio Sciences, Inc. Transaction History

Loomis Sayles & CO L P

$76.2 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$25.5 - $31.51 $859,146 - $1.06 Million	33,692 Added 8.9%	412,325 $11.8 Million
Q1 2024 May 14, 2024	BUY	$27.7 - $35.48 $1.44 Million - $1.84 Million	51,841 Added 15.86%	378,633 $11.1 Million
Q4 2023 Feb 13, 2024	SELL	$26.32 - $34.31 $1.27 Million - $1.65 Million	-48,188 Reduced 12.85%	326,792 $11 Million
Q3 2023 Nov 09, 2023	BUY	$30.68 - $40.09 $1.07 Million - $1.4 Million	34,811 Added 10.23%	374,980 $11.5 Million
Q2 2023 Aug 11, 2023	BUY	$36.12 - $47.5 $2.4 Million - $3.15 Million	66,353 Added 24.23%	340,169 $13.6 Million
Q1 2023 May 11, 2023	SELL	$35.53 - $43.38 $42.6 Million - $52 Million	-1,198,102 Reduced 81.4%	273,816 $11.2 Million
Q4 2022 Feb 10, 2023	BUY	$38.19 - $57.45 $1.27 Million - $1.91 Million	33,177 Added 2.31%	1,471,918 $56.8 Million
Q3 2022 Nov 14, 2022	BUY	$51.24 - $58.89 $7.84 Million - $9 Million	152,912 Added 11.89%	1,438,741 $76.5 Million
Q2 2022 Aug 05, 2022	SELL	$51.49 - $81.64 $405,277 - $642,588	-7,871 Reduced 0.61%	1,285,829 $75 Million
Q1 2022 May 13, 2022	BUY	$60.03 - $76.49 $6.18 Million - $7.88 Million	102,986 Added 8.65%	1,293,700 $98.7 Million
Q4 2021 Feb 14, 2022	BUY	$47.97 - $62.21 $1.86 Million - $2.42 Million	38,867 Added 3.37%	1,190,714 $71.6 Million
Q3 2021 Nov 12, 2021	BUY	$54.64 - $61.3 $1.4 Million - $1.57 Million	25,648 Added 2.28%	1,151,847 $64.5 Million
Q2 2021 Aug 13, 2021	SELL	$59.18 - $69.99 $377,805 - $446,816	-6,384 Reduced 0.56%	1,126,199 $68.3 Million
Q1 2021 May 17, 2021	SELL	$59.31 - $78.82 $104,978 - $139,511	-1,770 Reduced 0.16%	1,132,583 $79.4 Million
Q4 2020 Feb 12, 2021	BUY	$50.47 - $66.26 $14.8 Million - $19.4 Million	292,253 Added 34.71%	1,134,353 $67.9 Million
Q3 2020 Nov 12, 2020	BUY	$51.97 - $63.0 $824,659 - $999,684	15,868 Added 1.92%	842,100 $50.6 Million
Q2 2020 Aug 14, 2020	BUY	$30.8 - $52.47 $2.19 Million - $3.74 Million	71,236 Added 9.44%	826,232 $43.4 Million
Q1 2020 May 15, 2020	BUY	$28.4 - $50.7 $6.54 Million - $11.7 Million	230,403 Added 43.92%	754,996 $25.3 Million
Q4 2019 Feb 14, 2020	SELL	$36.31 - $46.83 $31,299 - $40,367	-862 Reduced 0.16%	524,593 $23.8 Million
Q3 2019 Nov 13, 2019	BUY	$35.66 - $44.99 $18.7 Million - $23.6 Million	525,455 New	525,455 $20 Million

Others Institutions Holding PCRX

# of Institutions

263

Shares Held

50.4M

Call Options Held

429K

Put Options Held

391K

Black Rock Inc. New York, NY

8.01M
Shares

$156 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

5.3M
Shares

$103 Million
0.0% of portfolio
Pacer Advisors, Inc. Malvern, PA

4.96M
Shares

$96.6 Million
0.18% of portfolio
State Street Corp Boston, MA

2.01M
Shares

$39.2 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

1.98M
Shares

$38.5 Million
0.05% of portfolio

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

News

Stay updated on Loomis Sayles & CO L P with notifications on news.

Account